---
category: trading
circular_id: 047e72bcc35f9995
date: '2025-11-14'
description: BSE announces the schedule for acquisition window (takeover offer) for
  J B Chemicals & Pharmaceuticals Ltd, scheduled from November 18 to December 1, 2025,
  with an offer price of Rs. 1,639.18 per share for up to 4.17 crore equity shares.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={585698A6-1680-4F04-BECE-DEBFF7EFC133}&noticeno=20251114-2&dt=11/14/2025&icount=2&totcount=15&flag=0
impact: high
impact_ranking: high
importance_ranking: high
justification: Major takeover offer involving significant number of shares (4.17 crore)
  at substantial premium, requiring participation through specific bidding procedures
  and systems during limited window period
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251114-2&attachedId=
processing:
  attempts: 1
  content_hash: 1f0d6328b443c217
  processed_at: '2025-11-14T12:47:20.483657'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-11-14T03:43:35+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={585698A6-1680-4F04-BECE-DEBFF7EFC133}&noticeno=20251114-2&dt=11/14/2025&icount=2&totcount=15&flag=0
severity: high
source: bse
stocks:
- JBCHEPHARM
tags:
- takeover
- acquisition-window
- offer-to-buy
- otb
- jbchepharm
- equity
- corporate-action
title: Offer to Buy â€“ Acquisition Window (Takeover) for J B Chemicals & Pharmaceuticals
  Ltd - Live Activities Schedule
---

## Summary

BSE has announced the detailed schedule for an acquisition window (takeover offer) for J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM). The offer will run from November 18, 2025 to December 1, 2025, targeting up to 41,745,264 equity shares at an offer price of Rs. 1,639.18 per share. Trading members and custodian members can participate through the iBBS platform and RTRMS systems during specified session timings.

## Key Points

- Security: J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM)
- ISIN: INE572A01036, Scrip Code: 506943
- Offer Size: Up to 4,17,45,264 equity shares
- Offer Price: Rs. 1,639.18 per share
- Face Value: Rs. 1.00, Market Lot: 1
- Opening Date: Tuesday, November 18, 2025
- Closing Date: Monday, December 1, 2025
- Bid Offering Period: 9:15 AM to 3:30 PM (Nov 18 - Dec 1, 2025)
- Give-up/Take-up Period: 9:15 AM to 3:30 PM (Nov 18 - Nov 28, 2025)
- Last day Give-up: 9:15 AM to 3:30 PM (Dec 1, 2025)
- Last day Take-up: 9:15 AM to 4:00 PM (Dec 1, 2025)
- Trading members can only bid for investors having shares in demat form
- UCC registration with correct PAN and category is mandatory

## Regulatory Changes

No new regulatory changes introduced. This circular operationalizes existing takeover regulations through BSE's Offer to Buy (OTB) mechanism as per previous notices 20150930-1 (September 30, 2015) and 20170203-29 (February 3, 2017).

## Compliance Requirements

- Trading Members must ensure investor UCC is registered/updated with correct PAN Number and Category in Exchange UCC database
- Members can only bid for investors holding shares in demat form
- Members must use designated systems: iBBS platform (Internet: https://ibbs.bseindia.com/ or Leased Line: https://ibbsll.bseindia.com/) and RTRMS (Internet: https://rtrms.bseindia.com/ or Leased Line: https://rtrmsll.bseindia.com/)
- Access Extranet (https://member.bseindia.com/ or https://memberll.bseindia.com/) for bid acceptance files
- Follow operational instructions per Exchange Notices 20150930-1 and 20170203-29
- Contact Trading Operations for login IDs and password resets (022-22728005, user.trdops@bseindia.com)

## Important Dates

- **November 14, 2025**: Circular notice date
- **November 18, 2025**: Offer opening date, bid offering period begins (9:15 AM)
- **November 18-28, 2025**: Give-up/Take-up period (9:15 AM - 3:30 PM)
- **December 1, 2025**: Offer closing date
  - Give-up (last day): 9:15 AM - 3:30 PM
  - Take-up (last day): 9:15 AM - 4:00 PM
  - Bid offering ends: 3:30 PM

## Impact Assessment

**Market Impact**: High - This is a significant takeover offer involving over 4.17 crore shares of a major pharmaceutical company at Rs. 1,639.18 per share, representing substantial transaction value. The offer allows participation from multiple investor categories including FIIs, mutual funds, insurance companies, and individuals.

**Operational Impact**: Trading members and custodians must prepare systems and processes for OTB participation within a tight 14-day window. Multiple bidding categories are available (FII, FI, MF, IC, OTH, NOH, CO, IND), requiring proper investor categorization and UCC management.

**Investor Impact**: Shareholders of JBCHEPHARM holding shares in demat form can tender their shares through their trading members during the specified period. The offer price represents the acquisition valuation for the takeover.

**Technical Requirements**: Members must ensure access to iBBS, RTRMS, and Extranet systems through both internet and leased line connections, with proper login credentials and password management through Trading Operations contact points.